Seres Therapeutics, Inc. financial data

Symbol
MCRB on Nasdaq
Location
200 Sidney Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134 % -26.5%
Quick Ratio 37.2 %
Debt-to-equity 417 %
Return On Equity 284 % -9.46%
Return On Assets 54.9 %
Operating Margin -63.5K % -100948%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.75M shares -94.2%
Common Stock, Shares, Outstanding 8.75M shares -94.2%
Entity Public Float 87.1M USD -81.2%
Common Stock, Value, Issued 9K USD -94.1%
Weighted Average Number of Shares Outstanding, Basic 8.74M shares +15.4%
Weighted Average Number of Shares Outstanding, Diluted 8.74M shares +15.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 374K USD -99.7%
Research and Development Expense 54.1M USD -13%
General and Administrative Expense 47.3M USD -14%
Operating Income (Loss) -110M USD +53.6%
Nonoperating Income (Expense) 56.3M USD +341%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 86M USD +39.6%
Earnings Per Share, Basic 11 USD/shares +47.7%
Earnings Per Share, Diluted 11 USD/shares +47.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 45.4M USD -36.3%
Inventory, Net 53M USD +892%
Assets, Current 48.7M USD -67.4%
Property, Plant and Equipment, Net 9.62M USD -45.9%
Operating Lease, Right-of-Use Asset 76.8M USD -25.6%
Other Assets, Noncurrent 31K USD -99.9%
Assets 144M USD -55.3%
Accounts Payable, Current 2.2M USD -54.3%
Employee-related Liabilities, Current 4.23M USD -43.1%
Liabilities, Current 30.9M USD -71.4%
Operating Lease, Liability, Noncurrent 78M USD -22.8%
Other Liabilities, Noncurrent 1.95M USD +13%
Liabilities 111M USD -72.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -965M USD +8.18%
Stockholders' Equity Attributable to Parent 33M USD
Liabilities and Equity 144M USD -55.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 26.9M USD
Net Cash Provided by (Used in) Financing Activities 1.18M USD -93.7%
Net Cash Provided by (Used in) Investing Activities -34M USD -54739%
Common Stock, Shares Authorized 360M shares 0%
Common Stock, Shares, Issued 8.75M shares -94.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -68.2M USD -156%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 54M USD -33.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 310M USD -0.98%
Deferred Tax Assets, Gross 331M USD -3.25%
Operating Lease, Liability 87.4M USD -20.6%
Payments to Acquire Property, Plant, and Equipment 34K USD -45.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 136K USD +62.1%
Lessee, Operating Lease, Liability, to be Paid 128M USD -23.9%
Property, Plant and Equipment, Gross 65M USD -9.3%
Operating Lease, Liability, Current 9.48M USD +3.08%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.6M USD -9.23%
Lessee, Operating Lease, Liability, to be Paid, Year One 20M USD -9.42%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 40.7M USD -30.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.9M USD -10.6%
Deferred Tax Assets, Operating Loss Carryforwards 156M USD +9.58%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 14M USD +3.59%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20.1M USD -14.6%
Operating Lease, Payments 18.1M USD +4.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.62M USD -26.5%
Share-based Payment Arrangement, Expense 14.1M USD -45.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%